Implementation of routine screening for Lynch syndrome in university and safety-net health system settings: Successes and challenges

Genetics in Medicine

Volumn 15, Issue 12, 2013, Pages 925-932

  Marquez, Evelyn ^a   Geng, Zhuo ^b   Pass, Sarah ^c   Summerour, Pia ^d   Robinson, Linda ^d   Sarode, Venetia ^b   Gupta, Samir ^e,f,g  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c FURMAN UNIVERSITY   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^g VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

colorectal cancer; genetic testing; immunohistochemistry; Lynch syndrome; routine screening

Indexed keywords

MISMATCH REPAIR PROTEIN PMS2; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6;

ADULT; AGED; ARTICLE; CANCER GENETICS; CANCER SCREENING; CLINICAL DECISION MAKING; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENETIC SCREENING; HEALTH CARE; HEALTH CARE QUALITY; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MEDICAL PRACTICE; OUTCOME ASSESSMENT; PATIENT SAFETY; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; UNIVERSITY;

ADULT; AGED; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DELIVERY OF HEALTH CARE; DNA MISMATCH REPAIR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; INTERNET; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SAFETY-NET PROVIDERS; UNIVERSITIES; YOUNG ADULT;

EID: 84884696396     PISSN: 10983600     EISSN: 15300366     Source Type: Journal    
DOI: 10.1038/gim.2013.45     Document Type: Article

References (26)

1. American Cancer Society. Cancer facts and figures. http://www.cancer.org/ Research/CancerFactsFigures/index
2. Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med 2003;348:919-932
3. Moreira L, Balaguer F, Lindor N, et al.; EPICOLON Consortium. Identification of Lynch syndrome among patients with colorectal cancer. JAMA 2012;308:1555-1565
4. Hampel H, Frankel WL, Martin E, et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 2005;352:1851-1860
5. Bonadona V, Bonaïti B, Olschwang S, et al.; French Cancer Genetics Network. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. JAMA 2011;305:2304-2310
6. National Comprehensive Cancer Network. NCCN Guidelines. http://www.nccn. org/professionals/physician-gls/f-guidelines.asp
7. Parry S, Win AK, Parry B, et al. Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: The advantage of more extensive colon surgery. Gut 2011;60:950-957
8. Kalady MF, McGannon E, Vogel JD, Manilich E, Fazio VW, Church JM. Risk of colorectal adenoma and carcinoma after colectomy for colorectal cancer in patients meeting Amsterdam criteria. Ann Surg 2010;252:507-511; discussion 511-513
9. Schmeler KM, Lynch HT, Chen LM, et al. Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N Engl J Med 2006;354: 261-269
10. Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group. Recommendations from the EGAPP Working Group: Genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genet Med 2009;11:35-41
11. Järvinen HJ, Aarnio M, Mustonen H, et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 2000;118:829-834
12. Ladabaum U, Wang G, Terdiman J, et al. Strategies to identify the Lynch syndrome among patients with colorectal cancer: A cost-effectiveness analysis. Ann Intern Med 2011;155:69-79
13. Boland CR, Shike M. Report from the Jerusalem workshop on Lynch syndromehereditary nonpolyposis colorectal cancer. Gastroenterology 2010;138:2197. e1-2197.e7
14. Khoury MJ, Coates RJ, Fennell ML, et al. Multilevel research and the challenges of implementing genomic medicine. J Natl Cancer Inst Monographs 2012;2012:112-120
15. Bellcross CA, Bedrosian SR, Daniels E, et al. Implementing screening for Lynch syndrome among patients with newly diagnosed colorectal cancer: Summary of a public health/clinical collaborative meeting. Genet Med 2012;14:152-162
16. Southey MC, Jenkins MA, Mead L, et al. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer. J Clin Oncol 2005;23:6524-6532
17. Palomaki GE, McClain MR, Melillo S, Hampel HL, Thibodeau SN. EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome. Genet Med 2009;11:42-65
18. Singh H, Schiesser R, Anand G, Richardson PA, El-Serag HB. Underdiagnosis of Lynch syndrome involves more than family history criteria. Clin Gastroenterol Hepatol 2010;8:523-529
19. van Lier MG, Leenen CH, Wagner A, et al.; LIMO Study Group. Yield of routine molecular analyses in colorectal cancer patients =70 years to detect underlying Lynch syndrome. J Pathol 2012;226:764-774
20. Mvundura M, Grosse SD, Hampel H, Palomaki GE. The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer. Genet Med 2010;12:93-104
21. Gudgeon JM, Williams JL, Burt RW, Samowitz WS, Snow GL, Williams MS. Lynch syndrome screening implementation: Business analysis by a healthcare system. Am J Manag Care 2011;17:e288-e300
22. Beamer LC, Grant ML, Espenschied CR, et al. Reflex immunohistochemistry and microsatellite instability testing of colorectal tumors for Lynch syndrome among US cancer programs and follow-up of abnormal results. J Clin Oncol 2012;30:1058-1063
23. Taplin SH, Rodgers AB. Toward improving the quality of cancer care: Addressing the interfaces of primary and oncology-related subspecialty care. J Natl Cancer Inst Monographs 2010;2010:3-10
24. Zapka J, Taplin SH, Ganz P, Grunfeld E, Sterba K. Multilevel factors affecting quality: Examples from the cancer care continuum. J Natl Cancer Inst Monographs 2012;2012:11-19
25. Gupta S, Ashfaq R, Kapur P, et al. Microsatellite instability among individuals of Hispanic origin with colorectal cancer. Cancer 2010;116:4965-4972
26. South CD, Yearsley M, Martin E, Arnold M, Frankel W, Hampel H. Immunohistochemistry staining for the mismatch repair proteins in the clinical care of patients with colorectal cancer. Genet Med 2009;11:812-817